The Billion Dollar Molecule | The Startup That Tried to Schedule Scientific Discovery

The Billion-Dollar Molecule begins with a question every biotechnology company eventually has to confront: can scientific discovery be turned into a schedule? Barry Werth follows the early years of Vertex Pharmaceuticals as scientists, executives and investors attempt to build a business around research whose most important breakthroughs cannot be promised in advance.At the center is Joshua Boger and his attempt to create a different kind of pharmaceutical company — one built around rational drug design and the belief that understanding molecules at a deeper level could make drug discovery more deliberate. Werth follows Vertex from the laboratory to Wall Street, through the search for new immunosuppressant drugs, competition around FK-506, financing negotiations and the pressure to turn scientific possibility into something investors can value.This episode explores why the book ultimately becomes less about one molecule than about the collision between two very different systems of time. Science advances through uncertainty, failed experiments and discoveries that refuse to arrive on demand. Companies survive through budgets, milestones, fundraising and promises about what comes next. Werth’s great subject is what happens when those worlds depend on each other — when scientists need capital to keep searching and investors need scientists to make the unpredictable sound temporarily predictable.If discovery cannot be scheduled, how do you build a company whose survival depends on knowing when the breakthrough will arrive?Subscribe to The Book Brief Project for deeper conversations about science, business and the books that reveal what innovation looks like before success makes it seem inevitable.─── ◈ ───The Billion-Dollar Molecule: One Company’s Quest for the Perfect Drug by Barry Werth · 1994Books, taken seriously. No quick summaries.New episodes when they're ready.──────────Narration in this episode is AI-assisted. The writing and the analysis are human.#TheBillionDollarMolecule #BarryWerth #VertexPharmaceuticals #JoshuaBoger #Biotechnology #Biotech #DrugDiscovery #PharmaceuticalIndustry #ScientificResearch #Innovation #Entrepreneurship #VentureCapital #ScienceAndBusiness #TheBookBriefProject #BookAnalysis #BookPodcast